nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Neurotoxicity—Vincristine—colon cancer	0.059	0.059	CcSEcCtD
Ethionamide—Neurotoxicity—Capecitabine—colon cancer	0.0384	0.0384	CcSEcCtD
Ethionamide—Taste metallic—Methotrexate—colon cancer	0.0349	0.0349	CcSEcCtD
Ethionamide—Neuritis—Vincristine—colon cancer	0.0306	0.0306	CcSEcCtD
Ethionamide—Neurotoxicity—Methotrexate—colon cancer	0.0286	0.0286	CcSEcCtD
Ethionamide—Hypothyroidism—Capecitabine—colon cancer	0.0232	0.0232	CcSEcCtD
Ethionamide—Salivary hypersecretion—Irinotecan—colon cancer	0.0216	0.0216	CcSEcCtD
Ethionamide—Photosensitivity—Fluorouracil—colon cancer	0.0176	0.0176	CcSEcCtD
Ethionamide—Orthostatic hypotension—Irinotecan—colon cancer	0.0148	0.0148	CcSEcCtD
Ethionamide—Erectile dysfunction—Vincristine—colon cancer	0.0132	0.0132	CcSEcCtD
Ethionamide—Photosensitivity reaction—Vincristine—colon cancer	0.0131	0.0131	CcSEcCtD
Ethionamide—Weight decreased—Vincristine—colon cancer	0.013	0.013	CcSEcCtD
Ethionamide—Depression—Vincristine—colon cancer	0.0128	0.0128	CcSEcCtD
Ethionamide—Weight decreased—Irinotecan—colon cancer	0.0126	0.0126	CcSEcCtD
Ethionamide—Neuropathy peripheral—Vincristine—colon cancer	0.0125	0.0125	CcSEcCtD
Ethionamide—Stomatitis—Vincristine—colon cancer	0.0125	0.0125	CcSEcCtD
Ethionamide—Photosensitivity—Capecitabine—colon cancer	0.0123	0.0123	CcSEcCtD
Ethionamide—Photosensitivity reaction—Fluorouracil—colon cancer	0.0122	0.0122	CcSEcCtD
Ethionamide—Jaundice—Irinotecan—colon cancer	0.0121	0.0121	CcSEcCtD
Ethionamide—Stomatitis—Irinotecan—colon cancer	0.0121	0.0121	CcSEcCtD
Ethionamide—Vascular purpura—Capecitabine—colon cancer	0.0121	0.0121	CcSEcCtD
Ethionamide—Neuropathy peripheral—Fluorouracil—colon cancer	0.0117	0.0117	CcSEcCtD
Ethionamide—Stomatitis—Fluorouracil—colon cancer	0.0116	0.0116	CcSEcCtD
Ethionamide—Purpura—Capecitabine—colon cancer	0.0112	0.0112	CcSEcCtD
Ethionamide—Diplopia—Capecitabine—colon cancer	0.0108	0.0108	CcSEcCtD
Ethionamide—Gynaecomastia—Methotrexate—colon cancer	0.00993	0.00993	CcSEcCtD
Ethionamide—Orthostatic hypotension—Capecitabine—colon cancer	0.00988	0.00988	CcSEcCtD
Ethionamide—Agitation—Vincristine—colon cancer	0.00919	0.00919	CcSEcCtD
Ethionamide—Photosensitivity—Methotrexate—colon cancer	0.00917	0.00917	CcSEcCtD
Ethionamide—Vision blurred—Fluorouracil—colon cancer	0.00879	0.00879	CcSEcCtD
Ethionamide—Photosensitivity reaction—Capecitabine—colon cancer	0.00853	0.00853	CcSEcCtD
Ethionamide—Weight decreased—Capecitabine—colon cancer	0.00846	0.00846	CcSEcCtD
Ethionamide—Depression—Capecitabine—colon cancer	0.00831	0.00831	CcSEcCtD
Ethionamide—Neuropathy peripheral—Capecitabine—colon cancer	0.00817	0.00817	CcSEcCtD
Ethionamide—Stomatitis—Capecitabine—colon cancer	0.00813	0.00813	CcSEcCtD
Ethionamide—Jaundice—Capecitabine—colon cancer	0.00813	0.00813	CcSEcCtD
Ethionamide—Thrombocytopenia—Vincristine—colon cancer	0.00799	0.00799	CcSEcCtD
Ethionamide—Thrombocytopenia—Irinotecan—colon cancer	0.00778	0.00778	CcSEcCtD
Ethionamide—Anorexia—Vincristine—colon cancer	0.00778	0.00778	CcSEcCtD
Ethionamide—Anorexia—Irinotecan—colon cancer	0.00757	0.00757	CcSEcCtD
Ethionamide—Hepatitis—Capecitabine—colon cancer	0.00748	0.00748	CcSEcCtD
Ethionamide—Thrombocytopenia—Fluorouracil—colon cancer	0.00745	0.00745	CcSEcCtD
Ethionamide—Anorexia—Fluorouracil—colon cancer	0.00725	0.00725	CcSEcCtD
Ethionamide—Decreased appetite—Vincristine—colon cancer	0.00709	0.00709	CcSEcCtD
Ethionamide—Somnolence—Irinotecan—colon cancer	0.00706	0.00706	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Vincristine—colon cancer	0.00704	0.00704	CcSEcCtD
Ethionamide—Dyspepsia—Irinotecan—colon cancer	0.00699	0.00699	CcSEcCtD
Ethionamide—Decreased appetite—Irinotecan—colon cancer	0.00691	0.00691	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.00686	0.00686	CcSEcCtD
Ethionamide—Somnolence—Fluorouracil—colon cancer	0.00676	0.00676	CcSEcCtD
Ethionamide—Dyspepsia—Fluorouracil—colon cancer	0.0067	0.0067	CcSEcCtD
Ethionamide—Gastrointestinal pain—Vincristine—colon cancer	0.00667	0.00667	CcSEcCtD
Ethionamide—Decreased appetite—Fluorouracil—colon cancer	0.00661	0.00661	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00657	0.00657	CcSEcCtD
Ethionamide—Gastrointestinal pain—Irinotecan—colon cancer	0.0065	0.0065	CcSEcCtD
Ethionamide—Abdominal pain—Vincristine—colon cancer	0.00645	0.00645	CcSEcCtD
Ethionamide—Erectile dysfunction—Methotrexate—colon cancer	0.00641	0.00641	CcSEcCtD
Ethionamide—Dysgeusia—Capecitabine—colon cancer	0.00638	0.00638	CcSEcCtD
Ethionamide—Photosensitivity reaction—Methotrexate—colon cancer	0.00635	0.00635	CcSEcCtD
Ethionamide—Abdominal pain—Irinotecan—colon cancer	0.00628	0.00628	CcSEcCtD
Ethionamide—Drowsiness—Methotrexate—colon cancer	0.00621	0.00621	CcSEcCtD
Ethionamide—Depression—Methotrexate—colon cancer	0.00619	0.00619	CcSEcCtD
Ethionamide—Vision blurred—Capecitabine—colon cancer	0.00614	0.00614	CcSEcCtD
Ethionamide—Stomatitis—Methotrexate—colon cancer	0.00605	0.00605	CcSEcCtD
Ethionamide—Hypersensitivity—Vincristine—colon cancer	0.00601	0.00601	CcSEcCtD
Ethionamide—Hypersensitivity—Irinotecan—colon cancer	0.00585	0.00585	CcSEcCtD
Ethionamide—Hypersensitivity—Fluorouracil—colon cancer	0.00561	0.00561	CcSEcCtD
Ethionamide—Diarrhoea—Vincristine—colon cancer	0.00558	0.00558	CcSEcCtD
Ethionamide—Hepatitis—Methotrexate—colon cancer	0.00557	0.00557	CcSEcCtD
Ethionamide—Diarrhoea—Irinotecan—colon cancer	0.00544	0.00544	CcSEcCtD
Ethionamide—Dizziness—Vincristine—colon cancer	0.00539	0.00539	CcSEcCtD
Ethionamide—Dizziness—Irinotecan—colon cancer	0.00525	0.00525	CcSEcCtD
Ethionamide—Diarrhoea—Fluorouracil—colon cancer	0.00521	0.00521	CcSEcCtD
Ethionamide—Thrombocytopenia—Capecitabine—colon cancer	0.00521	0.00521	CcSEcCtD
Ethionamide—Vomiting—Vincristine—colon cancer	0.00519	0.00519	CcSEcCtD
Ethionamide—Rash—Vincristine—colon cancer	0.00514	0.00514	CcSEcCtD
Ethionamide—Dermatitis—Vincristine—colon cancer	0.00514	0.00514	CcSEcCtD
Ethionamide—Headache—Vincristine—colon cancer	0.00511	0.00511	CcSEcCtD
Ethionamide—Anorexia—Capecitabine—colon cancer	0.00507	0.00507	CcSEcCtD
Ethionamide—Vomiting—Irinotecan—colon cancer	0.00505	0.00505	CcSEcCtD
Ethionamide—Dizziness—Fluorouracil—colon cancer	0.00503	0.00503	CcSEcCtD
Ethionamide—Rash—Irinotecan—colon cancer	0.00501	0.00501	CcSEcCtD
Ethionamide—Dermatitis—Irinotecan—colon cancer	0.005	0.005	CcSEcCtD
Ethionamide—Headache—Irinotecan—colon cancer	0.00498	0.00498	CcSEcCtD
Ethionamide—Nausea—Vincristine—colon cancer	0.00485	0.00485	CcSEcCtD
Ethionamide—Vomiting—Fluorouracil—colon cancer	0.00484	0.00484	CcSEcCtD
Ethionamide—Rash—Fluorouracil—colon cancer	0.0048	0.0048	CcSEcCtD
Ethionamide—Dermatitis—Fluorouracil—colon cancer	0.00479	0.00479	CcSEcCtD
Ethionamide—Headache—Fluorouracil—colon cancer	0.00477	0.00477	CcSEcCtD
Ethionamide—Dysgeusia—Methotrexate—colon cancer	0.00475	0.00475	CcSEcCtD
Ethionamide—Nausea—Irinotecan—colon cancer	0.00472	0.00472	CcSEcCtD
Ethionamide—Dyspepsia—Capecitabine—colon cancer	0.00468	0.00468	CcSEcCtD
Ethionamide—Decreased appetite—Capecitabine—colon cancer	0.00462	0.00462	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.00459	0.00459	CcSEcCtD
Ethionamide—Vision blurred—Methotrexate—colon cancer	0.00457	0.00457	CcSEcCtD
Ethionamide—Nausea—Fluorouracil—colon cancer	0.00452	0.00452	CcSEcCtD
Ethionamide—Gastrointestinal pain—Capecitabine—colon cancer	0.00435	0.00435	CcSEcCtD
Ethionamide—Abdominal pain—Capecitabine—colon cancer	0.0042	0.0042	CcSEcCtD
Ethionamide—Hypersensitivity—Capecitabine—colon cancer	0.00392	0.00392	CcSEcCtD
Ethionamide—Thrombocytopenia—Methotrexate—colon cancer	0.00388	0.00388	CcSEcCtD
Ethionamide—Anorexia—Methotrexate—colon cancer	0.00377	0.00377	CcSEcCtD
Ethionamide—Diarrhoea—Capecitabine—colon cancer	0.00364	0.00364	CcSEcCtD
Ethionamide—Somnolence—Methotrexate—colon cancer	0.00352	0.00352	CcSEcCtD
Ethionamide—Dizziness—Capecitabine—colon cancer	0.00352	0.00352	CcSEcCtD
Ethionamide—Dyspepsia—Methotrexate—colon cancer	0.00348	0.00348	CcSEcCtD
Ethionamide—Decreased appetite—Methotrexate—colon cancer	0.00344	0.00344	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Methotrexate—colon cancer	0.00342	0.00342	CcSEcCtD
Ethionamide—Vomiting—Capecitabine—colon cancer	0.00338	0.00338	CcSEcCtD
Ethionamide—Rash—Capecitabine—colon cancer	0.00335	0.00335	CcSEcCtD
Ethionamide—Dermatitis—Capecitabine—colon cancer	0.00335	0.00335	CcSEcCtD
Ethionamide—Headache—Capecitabine—colon cancer	0.00333	0.00333	CcSEcCtD
Ethionamide—Gastrointestinal pain—Methotrexate—colon cancer	0.00324	0.00324	CcSEcCtD
Ethionamide—Nausea—Capecitabine—colon cancer	0.00316	0.00316	CcSEcCtD
Ethionamide—Abdominal pain—Methotrexate—colon cancer	0.00313	0.00313	CcSEcCtD
Ethionamide—Hypersensitivity—Methotrexate—colon cancer	0.00292	0.00292	CcSEcCtD
Ethionamide—Diarrhoea—Methotrexate—colon cancer	0.00271	0.00271	CcSEcCtD
Ethionamide—Dizziness—Methotrexate—colon cancer	0.00262	0.00262	CcSEcCtD
Ethionamide—Vomiting—Methotrexate—colon cancer	0.00252	0.00252	CcSEcCtD
Ethionamide—Rash—Methotrexate—colon cancer	0.0025	0.0025	CcSEcCtD
Ethionamide—Dermatitis—Methotrexate—colon cancer	0.00249	0.00249	CcSEcCtD
Ethionamide—Headache—Methotrexate—colon cancer	0.00248	0.00248	CcSEcCtD
Ethionamide—Nausea—Methotrexate—colon cancer	0.00235	0.00235	CcSEcCtD
